Blue Jet Healthcare launches ₹600 crore fundraise via QIP

Shares of Blue Jet Healthcare Ltd will be in focus on Tuesday after the company launched a ₹600 crore qualified institutional placement (QIP) to raise growth capital.

The issue has an indicative price of ₹506 per equity share, representing a 10% discount to the stock's closing price of ₹572 on the NSE on Monday.

According to the company's exchange filing, the Investment and Finance Committee approved the preliminary placement document and authorised the opening of the issue on July 6. The committee also approved a floor price of ₹531.70 per share, determined in accordance with the pricing formula prescribed under the SEBI ICDR Regulations.

The company had earlier secured board approval for raising up to ₹1,000 crore through qualified institutional placements, preferential allotments, private placements or other permissible routes. Shareholders subsequently approved the proposal at an extraordinary general meeting held in June.

The fundraise comes after Blue Jet Healthcare reported a weaker set of quarterly earnings in May.

For the quarter ended March 2026, the company posted a 41.5% year-on-year decline in net profit to ₹64.3 crore, while revenue from operations fell 31% to ₹235 crore.

Also Read: Why the Indian rupee isn't recovering despite oil cooling off

EBITDA declined 49% to ₹71 crore, with the EBITDA margin contracting sharply to 30.3% from 41% a year earlier. Profit before tax stood at ₹87.1 crore, compared with ₹147.2 crore in the corresponding quarter last year, while total expenses declined to ₹170.4 crore from ₹205.4 crore.

Ahead of the announcement, shares of Blue Jet Healthcare Ltd ended 2.9% higher at ₹572 on the NSE.